SLC5A2 and Obesity: While Patient 7 had a preserved kidney function without any comorbidities, Patient 9 had proteinuria with obesity and required treatment with an angiotensin II receptor blocker (ARB) and a sodium glucose cotransporter 2 (SGLT2) inhibitor.